#Bimagrumab en el tratamiento de la #Obesidad (tras 48 semanas de tratamiento): 20.5% Grasa corporal 3.6% Masa magra (#músculo) En fase de hipertrofia muscular NO afecta al miocardio Combinado con #semaglutide o #tirzepatida potencia sus
xxxxArray
(
[status] => 1
[ID] => 1084095
[type] => 1
[edited] => 0
[album] => 677327
[USERID] => 1236447
[PID] => 0
[UID] => 0
[UIDO] => 0
[msg] => #Bimagrumab en el tratamiento de la #Obesidad (tras 48 semanas de tratamiento): 20.5% Grasa corporal 3.6% Masa magra (#músculo) En fase de hipertrofia muscular NO afecta al miocardio Combinado con #semaglutide o #tirzepatida potencia sus
[time_added] => 1667271791
[views] => 24
[repost] => 0
[liked] => 0
[origineid] => 0
[origineuser] => 0
[typepost] => 1
[com] => 0
[linkpost] => [linkpost2] =>
[realtime] => 1667530946
[costperview] => 0.00000
[button] => 0
[username] => endocrino.ped
[lastname] => PED
[firstname] => Endocrino
[verified] => 0
[public] => 1
[adult] => 0
[utype] => 134
[shorturl_id] =>
[shorturl_user] =>
)
1vvvvvv Comments 0